September 3, 2024
In the News
Press Releases and Media Coverage
July 31, 2024
Cancer Research: Attacking Cancer Through Activating “Big Eaters” of the Immune System
Read Article
June 26, 2024
PharmaShots: Macrophage Checkpoint Therapy with Roy Maute from Pheast Therapeutics
Read Article
May 13, 2024
Pheast Unveils First Preclinical Data for PHST001, an Anti-CD24 Macrophage Checkpoint Inhibitor
Read Article
January 5, 2024
Drug Target Review: The Potential of CD24 in Cancer Immunotherapy
Read Article
November 15, 2023
Pheast Featured as One of Nature Biotechnology’s Top Academic Spinouts for 2023
Read Article
May 10, 2023
In Vivo’s 2023 Rising Leaders: Healthcare Innovators At The Top Of Their Game
Read Article
April 26, 2022